Question · asked by 1 review

0.05% chlorhexidine + 0.05% cetylpyridinium chloride + 0.14% zinc lactate mouthrinse vs Placebo mouthwash: Adverse events

Population
Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological halitosis, non-oral halitosis, and severe chronic periodontitis (clinical attachment level 5 mm or more)
Intervention
0.05% chlorhexidine + 0.05% cetylpyridinium chloride + 0.14% zinc lactate mouthrinse
Comparison
Placebo mouthwash
Outcome
Adverse events

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Halita mouthwash (chlorhexidine 0.05% + cetylpyridinium chloride 0.05% + zinc lactate 0.14%) vs Placebo mouthwash
Adverse events · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced… · mean 2 weeks
Interventions for managing halitosis (2019) · Cochrane All outcomes
Adverse events (Table 6). Risk with placebo mouthwash: None reported. Risk with halita mouthwash: tongue staining was seen in patients who gargled, rather than rinsed. 40 participants (1 RCT). Certainty: VERY LOW.1 study · 40 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for managing halitosis
2019 · Cochrane All outcomes
2019-04Not listedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.